Long-Term Outcome of Hemimasticatory Spasm
- Author:
Somdattaa RAY
1
;
Nitish KAMBLE
;
Ravi YADAV
;
Pramod Kumar PAL
Author Information
- Publication Type:12
- From:Journal of Movement Disorders 2022;15(2):146-150
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:This study aims to identify the demographic, clinical, and therapeutic characteristics of four patients with hemimasticatory spasm (HMS) seen in our outpatient department over a period of 20 years.
Methods:We performed a retrospective chart review of four patients with HMS who visited outpatient services in the Department of Neurology from 2001 to 2020.
Results:The follow-up for all patients ranged from 2 years to 9 years. Three patients had facial or bucco-oral morphea. Two patients maintained long-term improvements in symptoms after being treated with botulinum toxin for 4–7 years, while one patient reported improvement in symptoms with treatment of carbamazepine that subsequently remitted after pregnancy.
Conclusion:This report highlights the long-term outcome of HMS in our patients. Our patients reported a significant reduction or complete resolution of symptoms after treatment, and eventually, two patients were asymptomatic while off treatment.
